Cancer treatment effects on cognition and depression

The moderating role of physical activity

Margaret F. Bedillion, Emily Ansell, Gwendolyn Thomas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. Materials and methods: 317 breast cancer survivors were recruited via Army of Women. Participants were 40–75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. Results: Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. Conclusion: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalBreast
Volume44
DOIs
StatePublished - Apr 1 2019

Fingerprint

Cognition
Exercise
Depression
Neoplasms
Breast Neoplasms
Survivors
Therapeutics
Drug Therapy
Passive Cutaneous Anaphylaxis
Aptitude
Tamoxifen
Epidemiologic Studies
Demography

Keywords

  • Breast cancer
  • Cancer treatment
  • Cognition
  • Depression
  • Physical activity

ASJC Scopus subject areas

  • Surgery

Cite this

Cancer treatment effects on cognition and depression : The moderating role of physical activity. / Bedillion, Margaret F.; Ansell, Emily; Thomas, Gwendolyn.

In: Breast, Vol. 44, 01.04.2019, p. 73-80.

Research output: Contribution to journalArticle

Bedillion, Margaret F. ; Ansell, Emily ; Thomas, Gwendolyn. / Cancer treatment effects on cognition and depression : The moderating role of physical activity. In: Breast. 2019 ; Vol. 44. pp. 73-80.
@article{0ca1784a397f4744b8ba375190188762,
title = "Cancer treatment effects on cognition and depression: The moderating role of physical activity",
abstract = "Objectives: Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. Materials and methods: 317 breast cancer survivors were recruited via Army of Women. Participants were 40–75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. Results: Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. Conclusion: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.",
keywords = "Breast cancer, Cancer treatment, Cognition, Depression, Physical activity",
author = "Bedillion, {Margaret F.} and Emily Ansell and Gwendolyn Thomas",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.breast.2019.01.004",
language = "English (US)",
volume = "44",
pages = "73--80",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Cancer treatment effects on cognition and depression

T2 - The moderating role of physical activity

AU - Bedillion, Margaret F.

AU - Ansell, Emily

AU - Thomas, Gwendolyn

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Objectives: Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. Materials and methods: 317 breast cancer survivors were recruited via Army of Women. Participants were 40–75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. Results: Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. Conclusion: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.

AB - Objectives: Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. Materials and methods: 317 breast cancer survivors were recruited via Army of Women. Participants were 40–75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. Results: Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. Conclusion: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.

KW - Breast cancer

KW - Cancer treatment

KW - Cognition

KW - Depression

KW - Physical activity

UR - http://www.scopus.com/inward/record.url?scp=85060928219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060928219&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2019.01.004

DO - 10.1016/j.breast.2019.01.004

M3 - Article

VL - 44

SP - 73

EP - 80

JO - Breast

JF - Breast

SN - 0960-9776

ER -